☰

Anthony Schulien - Publications

Affiliations: 
Neurobiology University of Pittsburgh, Pittsburgh, PA, United States 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Schulien AJ, Yeh CY, Orange BN, Pav OJ, Hopkins MP, Moutal A, Khanna R, Sun D, Justice JA, Aizenman E. Targeted disruption of Kv2.1-VAPA association provides neuroprotection against ischemic stroke in mice by declustering Kv2.1 channels. Science Advances. 6. PMID 32937450 DOI: 10.1126/Sciadv.Aaz8110  0.659
2020 Yeh CY, Schulien AJ, Molyneaux BJ, Aizenman E. Lessons from Recent Advances in Ischemic Stroke Management and Targeting Kv2.1 for Neuroprotection. International Journal of Molecular Sciences. 21. PMID 32854248 DOI: 10.3390/Ijms21176107  0.499
2019 XiangWei W, Kannan V, Xu Y, Kosobucki GJ, Schulien AJ, Kusumoto H, Moufawad El Achkar C, Bhattacharya S, Lesca G, Nguyen S, Helbig KL, Cuisset JM, Fenger CD, Marjanovic D, Schuler E, et al. Heterogeneous clinical and functional features of GRIN2D-related developmental and epileptic encephalopathy. Brain : a Journal of Neurology. PMID 31504254 DOI: 10.1093/Brain/Awz232  0.611
2018 Justice JA, Manjooran DT, Yeh CY, Hartnett-Scott KA, Schulien AJ, Kosobucki GJ, Mammen S, Palladino MJ, Aizenman E. Molecular neuroprotection induced by zinc-dependent expression of hepatitis C-derived protein NS5A targeting Kv2.1 potassium channels. The Journal of Pharmacology and Experimental Therapeutics. PMID 30190339 DOI: 10.1124/Jpet.118.252338  0.651
2017 Justice JA, Schulien AJ, He K, Hartnett KA, Aizenman E, Shah NH. Disruption of KV2.1 somato-dendritic clusters prevents the apoptogenic increase of potassium currents. Neuroscience. PMID 28461216 DOI: 10.1016/J.Neuroscience.2017.04.034  0.666
2017 Ogden KK, Chen W, Swanger SA, McDaniel MJ, Fan LZ, Hu C, Tankovic A, Kusumoto H, Kosobucki GJ, Schulien AJ, Su Z, Pecha J, Bhattacharya S, Petrovski S, Cohen AE, et al. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology. Plos Genetics. 13: e1006536. PMID 28095420 DOI: 10.1371/Journal.Pgen.1006536  0.58
2016 Li D, Yuan H, Ortiz-Gonzalez XR, Marsh ED, Tian L, McCormick EM, Kosobucki GJ, Chen W, Schulien AJ, Chiavacci R, Tankovic A, Naase C, Brueckner F, von Stülpnagel-Steinbeis C, Hu C, et al. GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers. American Journal of Human Genetics. PMID 27616483 DOI: 10.1016/J.Ajhg.2016.07.013  0.579
2016 Schulien AJ, Justice JA, Maio RD, Wills ZP, Shah NH, Aizenman E. Zn(2+) -Induced Ca(2+) release via ryanodine receptors triggers calcineurin-dependent redistribution of cortical neuronal Kv2.1 K(+) channels. The Journal of Physiology. PMID 26939666 DOI: 10.1113/Jp272117  0.664
2014 Shah NH, Schulien AJ, Clemens K, Aizenman TD, Hageman TM, Wills ZP, Aizenman E. Cyclin e1 regulates Kv2.1 channel phosphorylation and localization in neuronal ischemia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 4326-31. PMID 24647953 DOI: 10.1523/Jneurosci.5184-13.2014  0.643
Show low-probability matches.